Cite

HARVARD Citation

    Sekiguchi, N. et al. (2017). Preclinical evaluation of the potential for cytochrome P450 inhibition and induction of the selective ALK inhibitor, alectinib. Xenobiotica. pp. 1042-1051. [Online]. 
  
Back to record